During the past decade, Presidio Spedali Civili conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presidio Spedali Civili" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 2 trials as a collaborator, "INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA STUDY GROUP" with 1 trials as a collaborator and "The International Non-Hodgkin Lymphoma Prognostic Factor Project" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Presidio Spedali Civili" are "Lymphoma, Follicular" (1 trials) and "Lymphoma, T-Cell, Peripheral" (1 trials). Many other conditions were trialed in "Presidio Spedali Civili" in a lesser frequency.

The vast majority of trials in "Presidio Spedali Civili" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Presidio Spedali Civili". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Presidio Spedali Civili, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Presidio Spedali Civili, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".